MedWatch

Major investor: Many Europeans die without being offered the best medicine

International investor, CEO Florian Schönharting of NB Capital, believes that many Europeans, who suffer from some type of illness, are not offered the best medicine. Let us pay for it, for example with pension savings, he says. Committee president declines.

Foto: Gregers Tycho / Jyllands-Posten

Millions of sick people die in Europe every year oblivious to the fact that there are better treatment options than the ones they have been presented with, but often better and more expensive medicine is kept from them for financial reasons. Our society should, as a minimum, allow these terminally ill people to pay to get better medicine.

That is the firm message to the political decision makers from one of Denmark’s most experienced investors in the global biotech- and pharmaceutical-sector, CEO of NB Capital, Florian Schönharting.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Genmab-partner trækker sig fra samarbejde

Abbvie ønsker ikke længere at udvikle en fælles kræftkandidat med Genmab, men biotekselskabet skal stadig betale royalites af et eventuelt fremtidigt salg ved kommercialisering.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier